InvestorsHub Logo
Followers 32
Posts 2803
Boards Moderated 3
Alias Born 10/24/2015

Re: None

Friday, 08/06/2021 5:42:47 PM

Friday, August 06, 2021 5:42:47 PM

Post# of 263
The company anticipates filing of lead candidate CTX-001 in 18 to 24 months. More than 45 patients have been dosed across two trials and enrollment should be completed by the end of the year (we might get more data at ASH).

In addition, the company plans to report additional PhI data this year on CTX-110. Also, top-line PhI data from three trials by the end of the year on CTX-120 and CTX-130 (being tested in two trials).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRSP News